Vicapsys Life Sciences, Inc. (VICP)
1.00
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Vicapsys Life Sciences Gross Profit (TTM) : 0.00 for March 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.0078M |
| June 30, 2023 | -0.0156M |
| March 31, 2023 | -0.0235M |
| December 31, 2022 | -0.0313M |
| September 30, 2022 | -0.0313M |
| June 30, 2022 | -0.0313M |
| March 31, 2022 | -0.0313M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.0313M |
| September 30, 2021 | -0.0313M |
| June 30, 2021 | -0.0313M |
| March 31, 2021 | -0.0314M |
| December 31, 2020 | -0.0314M |
| September 30, 2020 | -0.0289M |
| June 30, 2020 | -0.0289M |
| March 31, 2020 | -0.021M |
| December 31, 2019 | -0.3253M |
| June 30, 2019 | -0.3838M |
| December 31, 2018 | -0.376M |
| March 31, 2010 | -0.376M |
| March 31, 2009 | -0.0639M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.117B |
| Anixa Biosciences, Inc. | -0.039M |